Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino

doi:10.1016/S0140-6736(15)00075-6

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

Geltrude Mingrone, Simona Panunzi, Andrea De Gaetano, Caterina Guidone, Amerigo Iaconelli, Giuseppe Nanni, Marco Castagneto, Stefan Bornstein, Francesco Rubino

Risultato della ricerca: Contributo in rivista › Articolo in rivista

626 Citazioni (Scopus)

Abstract

Randomised controlled trials have shown that bariatric surgery is more effective than conventional treatment for the short-term control of type-2 diabetes. However, published studies are characterised by a relatively short follow-up. We aimed to assess 5 year outcomes from our randomised trial designed to compare surgery with conventional medical treatment for the treatment of type 2 diabetes in obese patients.

Lingua originale	English
pagine (da-a)	964-973
Numero di pagine	10
Rivista	The Lancet
Volume	386
DOI	https://doi.org/10.1016/S0140-6736(15)00075-6
Stato di pubblicazione	Pubblicato - 2015

Keywords

Adult
Bariatric Surgery
Blood Glucose
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Follow-Up Studies
Hemoglobin A, Glycosylated
Humans
Hyperglycemia
Italy
Middle Aged
Obesity
Quality of Life
Risk Factors
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1016/S0140-6736(15)00075-6

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Mingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015). Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. The Lancet, 386, 964-973. https://doi.org/10.1016/S0140-6736(15)00075-6

@article{f900610bee1a4bf88c8e94f68ab07a2d,

title = "Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial",

abstract = "Randomised controlled trials have shown that bariatric surgery is more effective than conventional treatment for the short-term control of type-2 diabetes. However, published studies are characterised by a relatively short follow-up. We aimed to assess 5 year outcomes from our randomised trial designed to compare surgery with conventional medical treatment for the treatment of type 2 diabetes in obese patients.",

keywords = "Adult, Bariatric Surgery, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Follow-Up Studies, Hemoglobin A, Glycosylated, Humans, Hyperglycemia, Italy, Middle Aged, Obesity, Quality of Life, Risk Factors, Treatment Outcome, Adult, Bariatric Surgery, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Follow-Up Studies, Hemoglobin A, Glycosylated, Humans, Hyperglycemia, Italy, Middle Aged, Obesity, Quality of Life, Risk Factors, Treatment Outcome",

author = "Geltrude Mingrone and Simona Panunzi and {De Gaetano}, Andrea and Caterina Guidone and Amerigo Iaconelli and Giuseppe Nanni and Marco Castagneto and Stefan Bornstein and Francesco Rubino",

year = "2015",

doi = "10.1016/S0140-6736(15)00075-6",

language = "English",

volume = "386",

pages = "964--973",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

}

Mingrone, G, Panunzi, S, De Gaetano, A, Guidone, C, Iaconelli, A, Nanni, G, Castagneto, M, Bornstein, S & Rubino, F 2015, 'Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial', The Lancet, vol. 386, pagg. 964-973. https://doi.org/10.1016/S0140-6736(15)00075-6

TY - JOUR

T1 - Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

AU - Mingrone, Geltrude

AU - Panunzi, Simona

AU - De Gaetano, Andrea

AU - Guidone, Caterina

AU - Iaconelli, Amerigo

AU - Nanni, Giuseppe

AU - Castagneto, Marco

AU - Bornstein, Stefan

AU - Rubino, Francesco

PY - 2015

Y1 - 2015

N2 - Randomised controlled trials have shown that bariatric surgery is more effective than conventional treatment for the short-term control of type-2 diabetes. However, published studies are characterised by a relatively short follow-up. We aimed to assess 5 year outcomes from our randomised trial designed to compare surgery with conventional medical treatment for the treatment of type 2 diabetes in obese patients.

AB - Randomised controlled trials have shown that bariatric surgery is more effective than conventional treatment for the short-term control of type-2 diabetes. However, published studies are characterised by a relatively short follow-up. We aimed to assess 5 year outcomes from our randomised trial designed to compare surgery with conventional medical treatment for the treatment of type 2 diabetes in obese patients.

KW - Adult

KW - Bariatric Surgery

KW - Blood Glucose

KW - Cardiovascular Diseases

KW - Diabetes Mellitus, Type 2

KW - Follow-Up Studies

KW - Hemoglobin A, Glycosylated

KW - Humans

KW - Hyperglycemia

KW - Italy

KW - Middle Aged

KW - Obesity

KW - Quality of Life

KW - Risk Factors

KW - Treatment Outcome

KW - Adult

KW - Bariatric Surgery

KW - Blood Glucose

KW - Cardiovascular Diseases

KW - Diabetes Mellitus, Type 2

KW - Follow-Up Studies

KW - Hemoglobin A, Glycosylated

KW - Humans

KW - Hyperglycemia

KW - Italy

KW - Middle Aged

KW - Obesity

KW - Quality of Life

KW - Risk Factors

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/70853

U2 - 10.1016/S0140-6736(15)00075-6

DO - 10.1016/S0140-6736(15)00075-6

M3 - Article

SN - 0140-6736

VL - 386

SP - 964

EP - 973

JO - The Lancet

JF - The Lancet

ER -

Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo